SONOSCAPE(SZ:300633) Sou Hu Cai Jing·2026-02-24 12:56Group 1 - The core viewpoint of the article highlights the financial performance and stock activity of Kaili Medical (300633) as of February 24, 2026, with a closing price of 26.62 yuan, reflecting a slight increase of 0.08% [1] - The company reported a main revenue of 1.459 billion yuan for the first three quarters of 2025, showing a year-on-year increase of 4.37%, while the net profit attributable to shareholders decreased by 69.25% to 33.51 million yuan [2] - In the third quarter of 2025, the company achieved a single-quarter main revenue of 495 million yuan, up 28.42% year-on-year, but reported a net loss of 13.52 million yuan, which is an increase of 78.05% compared to the previous year [2] Group 2 - The company has a debt ratio of 24.22% and reported an investment income of 2.08 million yuan, with financial expenses amounting to -38.30 million yuan and a gross profit margin of 60.36% [2] - Over the last 90 days, four institutions have provided ratings for the stock, with three giving a buy rating and one an increase rating [3] - The article explains the concept of fund flow, indicating that the net flow of funds is determined by the difference between the buying and selling pressures in the market [3]